In the BioHarmony Drug Report Database
Decitabine
Dacogen, Decitabine (decitabine) is a small molecule pharmaceutical. Decitabine was first approved as Dacogen on 2006-05-02. It is used to treat myelodysplastic syndromes in the USA. It has been approved in Europe to treat myeloid leukemia. It is known to target cytidine deaminase.
Trade Name
|
Dacogen |
|---|---|
Common Name
|
decitabine |
ChEMBL ID
|
CHEMBL1201129 |
Indication
|
myelodysplastic syndromes, myeloid leukemia |
Drug Class
|
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein)